These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12583750)

  • 1. Toward a structure-activity relationship for apoptolidin: selective functionalization of the hydroxyl group array.
    Wender PA; Jankowski OD; Tabet EA; Seto H
    Org Lett; 2003 Feb; 5(4):487-90. PubMed ID: 12583750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile synthetic access to and biological evaluation of the macrocyclic core of apoptolidin.
    Wender PA; Jankowski OD; Tabet EA; Seto H
    Org Lett; 2003 Jun; 5(13):2299-302. PubMed ID: 12816433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
    Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
    J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoapoptolidin: structure and activity of the ring-expanded isomer of apoptolidin.
    Wender PA; Gulledge AV; Jankowski OD; Seto H
    Org Lett; 2002 Oct; 4(22):3819-22. PubMed ID: 12599467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a stable apoptolidin derivative: identification of isoapoptolidin and selective deglycosylation of apoptolidin.
    Pennington JD; Williams HJ; Salomon AR; Sulikowski GA
    Org Lett; 2002 Oct; 4(22):3823-5. PubMed ID: 12599468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase.
    Salomon AR; Voehringer DW; Herzenberg LA; Khosla C
    Chem Biol; 2001 Jan; 8(1):71-80. PubMed ID: 11182320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bafilomycins and related compounds as vacuolar H(+)-ATPase inhibitors].
    Moriyama Y; Futai M; Yoshimori T; Yamamoto A; Tashiro Y
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):2000-11. PubMed ID: 8210440
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity relationships within a family of selectively cytotoxic macrolide natural products.
    Salomon AR; Zhang Y; Seto H; Khosla C
    Org Lett; 2001 Jan; 3(1):57-9. PubMed ID: 11429871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase.
    Salomon AR; Voehringer DW; Herzenberg LA; Khosla C
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14766-71. PubMed ID: 11121076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues.
    Wender PA; Jankowski OD; Longcore K; Tabet EA; Seto H; Tomikawa T
    Org Lett; 2006 Feb; 8(4):589-92. PubMed ID: 16468718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of biological activity of macrolide antibiotics--inhibitors of F0F1-ATPase].
    Bibikova MV; Grammatikova NE; Kabanov AE; Sazykin IuO; Katlinskiĭ AV
    Antibiot Khimioter; 2003; 48(12):33-9. PubMed ID: 15176103
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue-selective inhibition of vacuolar acid pumps.
    Keeling DJ; Herslöf M; Mattsson JP; Ryberg B
    Acta Physiol Scand Suppl; 1998 Aug; 643():195-201. PubMed ID: 9789561
    [No Abstract]   [Full Text] [Related]  

  • 13. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases.
    Dröse S; Altendorf K
    J Exp Biol; 1997 Jan; 200(Pt 1):1-8. PubMed ID: 9023991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of cruentaren A analogues.
    Vintonyak VV; Calà M; Lay F; Kunze B; Sasse F; Maier ME
    Chemistry; 2008; 14(12):3709-20. PubMed ID: 18306263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neopikromycin and novapikromycin from the pikromycin biosynthetic pathway of Streptomyces venezuelae.
    Lee SK; Park JW; Kim JW; Jung WS; Park SR; Choi CY; Kim ES; Kim BS; Ahn JS; Sherman DH; Yoon YJ
    J Nat Prod; 2006 May; 69(5):847-9. PubMed ID: 16724858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of derivatives of 6-O-allylic acylides.
    Xu P; Liu L; Jin Z; Lei P
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3330-4. PubMed ID: 17459704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total syntheses of amphidinolides B1, B4, G1, H1 and structure revision of amphidinolide H2.
    Fürstner A; Bouchez LC; Morency L; Funel JA; Liepins V; Porée FH; Gilmour R; Laurich D; Beaufils F; Tamiya M
    Chemistry; 2009; 15(16):3983-4010. PubMed ID: 19241433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A convergent ring-closing metathesis approach to carbohydrate-based macrolides with potential antibiotic activity.
    Blom P; Ruttens B; Van Hoof S; Hubrecht I; Van der Eycken J; Sas B; Van hemel J; Vandenkerckhove J
    J Org Chem; 2005 Nov; 70(24):10109-12. PubMed ID: 16292849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 16-membered macrolides modified at C-12 and C-13 positions of midecamycin A1 and miokamycin. Part 1: Synthesis and evaluation of 12,13-carbamate and 12-arylalkylamino-13-hydroxy analogues.
    Miura T; Kurihara K; Furuuchi T; Yoshida T; Ajito K
    Bioorg Med Chem; 2008 Apr; 16(7):3985-4002. PubMed ID: 18258437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure-activity relationships of salicylic acid and its analogs in the inhibitory action on beta-lactamase].
    Yang ZC; Yang XS; Wang BC; Sun QY
    Yao Xue Xue Bao; 2006 Mar; 41(3):230-2. PubMed ID: 16758993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.